• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Bavarian Nordic A/S

+ Add to Watchlist

BV3:GR

26.236 EUR 0.309 1.16%

As of 08:09:19 ET on 12/23/2014.

Snapshot for Bavarian Nordic A/S (BV3)

Open: 26.145 Day's Range: 26.145 - 26.615 Volume: 544
Previous Close: 26.545 52wk Range: 10.960 - 27.292 1-Yr Rtn: +136.06%

Stock Chart for BV3

No chart data available.
  • BV3:GR 26.236
  • 1D
  • 1M
  • 1Y
26.545
Interactive BV3 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BV3

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 151.7484
Relative P/E vs. DAX -
Earnings Per Share (DKK) (ttm) -
Est. EPS (DKK) (12/2014) 1.2860
Est. PEG Ratio -
Market Cap (M EUR) 725.98
Shares Outstanding (M) 27.67
30 Day Average Volume 417
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/11/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BV3

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for BV3

Bavarian Nordic A/S is a biotechnology company developing and producing vaccines for the treatment and prevention of cancer and infectious diseases. The company also manufactures and delivers modern smallpox vaccines for governments under national emergency rules.

Gerard W M Van OdijkChairmanPaul ChaplinPresident/CEO
James B Breitmeyer "Jim"Pres:Cancer/Exec VPOle LarsenExec VP/CFO
More Company Profile & Key Executives for BV3

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil